The U.S. Environmental Protection Agency is expected to finalize regulatory changes that would provide new requirements for managing hazardous waste pharmaceuticals later this year, according to an article on The Legal Intelligencer website.
The EPA has proposed changes to codify requirements for the common practice of returning these products to manufacturers and to clarify other ambiguities with respect to managing hazardous waste pharmaceuticals (HWP).
These changes should reduce the amount of HWP that is poured down drains and often passes through sewer treatment processes, thereby improving water quality in drinking water sources.
Pharmaceutical waste generated by healthcare facilities will fall into one of three categories — potentially creditable HWP, noncreditable HWP and non-HWP.
Cleanliness in Hospitals: Clinical Priority and Community Perception
Dana-Farber Receives $50M Gift for Planned Cancer Hospital
Clarinda Regional Health Center Reports Data Security Incident
Gaps in Nurses' Environmental Cleaning Knowledge Grow Amid Rising EVS Pressures
Ground Broken on the Southern Nevada Forensic Facility